Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Diagnostic Nuclear Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diagnostic Nuclear Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diagnostic Nuclear Drug Overall Market Size
2.1 Global Diagnostic Nuclear Drug Market Size: 2021 VS 2028
2.2 Global Diagnostic Nuclear Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Diagnostic Nuclear Drug Players in Global Market
3.2 Top Global Diagnostic Nuclear Drug Companies Ranked by Revenue
3.3 Global Diagnostic Nuclear Drug Revenue by Companies
3.4 Top 3 and Top 5 Diagnostic Nuclear Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Diagnostic Nuclear Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diagnostic Nuclear Drug Players in Global Market
3.6.1 List of Global Tier 1 Diagnostic Nuclear Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Diagnostic Nuclear Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Diagnostic Nuclear Drug Market Size Markets, 2021 & 2028
4.1.2 Tc-99m
4.1.3 F-18
4.1.4 Other
4.2 By Type - Global Diagnostic Nuclear Drug Revenue & Forecasts
4.2.1 By Type - Global Diagnostic Nuclear Drug Revenue, 2017-2022
4.2.2 By Type - Global Diagnostic Nuclear Drug Revenue, 2023-2028
4.2.3 By Type - Global Diagnostic Nuclear Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diagnostic Nuclear Drug Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Other
5.2 By Application - Global Diagnostic Nuclear Drug Revenue & Forecasts
5.2.1 By Application - Global Diagnostic Nuclear Drug Revenue, 2017-2022
5.2.2 By Application - Global Diagnostic Nuclear Drug Revenue, 2023-2028
5.2.3 By Application - Global Diagnostic Nuclear Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Diagnostic Nuclear Drug Market Size, 2021 & 2028
6.2 By Region - Global Diagnostic Nuclear Drug Revenue & Forecasts
6.2.1 By Region - Global Diagnostic Nuclear Drug Revenue, 2017-2022
6.2.2 By Region - Global Diagnostic Nuclear Drug Revenue, 2023-2028
6.2.3 By Region - Global Diagnostic Nuclear Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Diagnostic Nuclear Drug Revenue, 2017-2028
6.3.2 US Diagnostic Nuclear Drug Market Size, 2017-2028
6.3.3 Canada Diagnostic Nuclear Drug Market Size, 2017-2028
6.3.4 Mexico Diagnostic Nuclear Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Diagnostic Nuclear Drug Revenue, 2017-2028
6.4.2 Germany Diagnostic Nuclear Drug Market Size, 2017-2028
6.4.3 France Diagnostic Nuclear Drug Market Size, 2017-2028
6.4.4 U.K. Diagnostic Nuclear Drug Market Size, 2017-2028
6.4.5 Italy Diagnostic Nuclear Drug Market Size, 2017-2028
6.4.6 Russia Diagnostic Nuclear Drug Market Size, 2017-2028
6.4.7 Nordic Countries Diagnostic Nuclear Drug Market Size, 2017-2028
6.4.8 Benelux Diagnostic Nuclear Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Diagnostic Nuclear Drug Revenue, 2017-2028
6.5.2 China Diagnostic Nuclear Drug Market Size, 2017-2028
6.5.3 Japan Diagnostic Nuclear Drug Market Size, 2017-2028
6.5.4 South Korea Diagnostic Nuclear Drug Market Size, 2017-2028
6.5.5 Southeast Asia Diagnostic Nuclear Drug Market Size, 2017-2028
6.5.6 India Diagnostic Nuclear Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Diagnostic Nuclear Drug Revenue, 2017-2028
6.6.2 Brazil Diagnostic Nuclear Drug Market Size, 2017-2028
6.6.3 Argentina Diagnostic Nuclear Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diagnostic Nuclear Drug Revenue, 2017-2028
6.7.2 Turkey Diagnostic Nuclear Drug Market Size, 2017-2028
6.7.3 Israel Diagnostic Nuclear Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Diagnostic Nuclear Drug Market Size, 2017-2028
6.7.5 UAE Diagnostic Nuclear Drug Market Size, 2017-2028
7 Players Profiles
7.1 Bracco Imaging
7.1.1 Bracco Imaging Corporate Summary
7.1.2 Bracco Imaging Business Overview
7.1.3 Bracco Imaging Diagnostic Nuclear Drug Major Product Offerings
7.1.4 Bracco Imaging Diagnostic Nuclear Drug Revenue in Global Market (2017-2022)
7.1.5 Bracco Imaging Key News
7.2 Bayer
7.2.1 Bayer Corporate Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Diagnostic Nuclear Drug Major Product Offerings
7.2.4 Bayer Diagnostic Nuclear Drug Revenue in Global Market (2017-2022)
7.2.5 Bayer Key News
7.3 Curium Pharmaceuticals
7.3.1 Curium Pharmaceuticals Corporate Summary
7.3.2 Curium Pharmaceuticals Business Overview
7.3.3 Curium Pharmaceuticals Diagnostic Nuclear Drug Major Product Offerings
7.3.4 Curium Pharmaceuticals Diagnostic Nuclear Drug Revenue in Global Market (2017-2022)
7.3.5 Curium Pharmaceuticals Key News
7.4 Nordion
7.4.1 Nordion Corporate Summary
7.4.2 Nordion Business Overview
7.4.3 Nordion Diagnostic Nuclear Drug Major Product Offerings
7.4.4 Nordion Diagnostic Nuclear Drug Revenue in Global Market (2017-2022)
7.4.5 Nordion Key News
7.5 Triad Isotopes
7.5.1 Triad Isotopes Corporate Summary
7.5.2 Triad Isotopes Business Overview
7.5.3 Triad Isotopes Diagnostic Nuclear Drug Major Product Offerings
7.5.4 Triad Isotopes Diagnostic Nuclear Drug Revenue in Global Market (2017-2022)
7.5.5 Triad Isotopes Key News
7.6 Lantheus
7.6.1 Lantheus Corporate Summary
7.6.2 Lantheus Business Overview
7.6.3 Lantheus Diagnostic Nuclear Drug Major Product Offerings
7.6.4 Lantheus Diagnostic Nuclear Drug Revenue in Global Market (2017-2022)
7.6.5 Lantheus Key News
7.7 GE Healthcare
7.7.1 GE Healthcare Corporate Summary
7.7.2 GE Healthcare Business Overview
7.7.3 GE Healthcare Diagnostic Nuclear Drug Major Product Offerings
7.7.4 GE Healthcare Diagnostic Nuclear Drug Revenue in Global Market (2017-2022)
7.7.5 GE Healthcare Key News
7.8 China Isotope & Radiation
7.8.1 China Isotope & Radiation Corporate Summary
7.8.2 China Isotope & Radiation Business Overview
7.8.3 China Isotope & Radiation Diagnostic Nuclear Drug Major Product Offerings
7.8.4 China Isotope & Radiation Diagnostic Nuclear Drug Revenue in Global Market (2017-2022)
7.8.5 China Isotope & Radiation Key News
7.9 Jubilant Pharma
7.9.1 Jubilant Pharma Corporate Summary
7.9.2 Jubilant Pharma Business Overview
7.9.3 Jubilant Pharma Diagnostic Nuclear Drug Major Product Offerings
7.9.4 Jubilant Pharma Diagnostic Nuclear Drug Revenue in Global Market (2017-2022)
7.9.5 Jubilant Pharma Key News
7.10 Eli Lilly
7.10.1 Eli Lilly Corporate Summary
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Diagnostic Nuclear Drug Major Product Offerings
7.10.4 Eli Lilly Diagnostic Nuclear Drug Revenue in Global Market (2017-2022)
7.10.5 Eli Lilly Key News
7.11 Novartis
7.11.1 Novartis Corporate Summary
7.11.2 Novartis Business Overview
7.11.3 Novartis Diagnostic Nuclear Drug Major Product Offerings
7.11.4 Novartis Diagnostic Nuclear Drug Revenue in Global Market (2017-2022)
7.11.5 Novartis Key News
7.12 SIEMENS
7.12.1 SIEMENS Corporate Summary
7.12.2 SIEMENS Business Overview
7.12.3 SIEMENS Diagnostic Nuclear Drug Major Product Offerings
7.12.4 SIEMENS Diagnostic Nuclear Drug Revenue in Global Market (2017-2022)
7.12.5 SIEMENS Key News
7.13 Dongcheng
7.13.1 Dongcheng Corporate Summary
7.13.2 Dongcheng Business Overview
7.13.3 Dongcheng Diagnostic Nuclear Drug Major Product Offerings
7.13.4 Dongcheng Diagnostic Nuclear Drug Revenue in Global Market (2017-2022)
7.13.5 Dongcheng Key News
7.14 Navidea
7.14.1 Navidea Corporate Summary
7.14.2 Navidea Business Overview
7.14.3 Navidea Diagnostic Nuclear Drug Major Product Offerings
7.14.4 Navidea Diagnostic Nuclear Drug Revenue in Global Market (2017-2022)
7.14.5 Navidea Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer